Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
4D pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
£0
2023-02-14
Market Capitalization
£30 M
2023-02-14
Revenue
£522 K
FY, 2021
CreditSafe Score
?
Score changed on Jun 15, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|
| Revenue | 211.0K | 534.0K | 522.0K | |
| Gross profit | 245.0K | 579.0K | 558.0K | |
| Gross profit margin, % | 116.1% | 108.4% | 106.9% | |
| Operating expense total | 27.9M | 29.6M | 29.9M | 70.5M |
| Depreciation and amortization | 1.2M | 1.3M | 1.2M | 976.0K |
| EBITDA | (27.9M) | (29.3M) | (29.3M) | (69.9M) |
| EBITDA margin, % | -13901.9% | -5493.6% | -13397.3% | |
| EBIT | (29.1M) | (28.0M) | (30.5M) | (57.3M) |
| EBIT margin, % | -13248.8% | -5719.3% | -10973.8% | |
| Interest income | 282.0K | 61.0K | 5.0K | 1.0K |
| Interest expense | 348.0K | 514.0K | 173.0K | 610.0K |
| Pre tax profit | (28.4M) | (29.4M) | (30.3M) | (57.5M) |
| Income tax expense | (4.7M) | (5.4M) | (4.4M) | (3.5M) |
| Net Income | (23.7M) | (24.1M) | (26.0M) | (54.0M) |